Verdeso (VER-des-oh) is the first topical corticosteroid FOAM

July 2011

Verdeso (VER-des-oh) is the first topical corticosteroid FOAM in Canada.

It will be used for mild to moderate atopic dermatitis.

Verdeso contains desonide 0.05%...a low potency steroid. It's for patients one year and older...and can be used for up to 4 weeks.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Dyslipidemia Lots of patients are asking if they should stop taking niacin (Niaspan, etc) for dyslipidemia
Antiplatelets Brilinta (ticagrelor) will compete with Plavix and Effient
Diabetes Actos might cause bladder cancer
Diabetes how to manage diabetes during fasting
Thyroid Disorders Many older adults get too much levothyroxine (Synthroid, etc)
Antidepressants Oleptro, a new extended-release trazodone for depression
Antidepressants Is it okay to combine an SSRI (fluoxetine, etc) with an SNRI (Effexor XR, Cymbalta)
Respiratory & Allergy Singulair is "as good as" inhaled corticosteroids or long-acting beta-agonists for asthma
Neurology & Pain Abstral (AB-stral) is a new fentanyl sublingual tab for breakthrough pain in cancer patients
Dermatology Verdeso (VER-des-oh) is the first topical corticosteroid FOAM
Infectious Diseases We're running out of antibiotics for multidrug-resistant gram-negative "superbugs"
Statins limiting doses of simvastatin (Zocor, etc)